Fundraising FoxWing — 2024 Investments
8 investments dated 2024 · listed companies and verified rows first · show all
Zipline is a data infrastructure platform built on the open-source Chronon project that lets engineering teams build, deploy, and monitor real-time data pipelines, features, and embeddings for AI agents and ML models.
AI & Machine LearningData & InfrastructureDeveloper ToolsUnion City, US
Nikhil Simha Raprolu(Executive Officer, Director, Promoter)Nikhil Simha(Co-Founder & CTO)inVarant Zanoyan(Co-Founder & CEO)inPiyush Narang(Chief Architect)in
Board seatChris Zeoli· per SEC Form D
Co-investorsBoxGroupMaterialized View CapitalTwine VenturesAndreessen HorowitzBaillie GiffordFidelity Investments+8 more
AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.
AI & Machine LearningData & InfrastructureDeep TechHardwareMenlo Park, US
Joy Laskar(AttoTude Founder and CTO)inDave Welch(AttoTude Founder and CEO)in
BoardPeter Wagner(Director)inBasil Alwan(Director)
Co-investorsCanaan PartnersThe Westly GroupSutter Hill VenturesMayfield FundNosTerra Venture CapitalOpen Field Capital+1 more
Billables AI provides automated timekeeping software that uses AI to track billable activity while professionals work, generating time entries with associated clients, matters, and narrative descriptions.
AI & Machine LearningLegalTechSaaSSan Francisco, US
Arvind Sujeeth(Founder)inNancy Jeng(Founder)in
Co-investorsAvenue Growth PartnersDarkmode Venturesf7 VenturesSignalFire
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.
BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US
Sasan Amini(Co-Founder and CEO)inRamin Khaksar(Co-Founder, CSO, and COO)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)
Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+23 more
Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.
BiotechDeep TechBerkeley, US
Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)
BoardCraig Asher(Director)inJimmy Yun(Director)in
Co-investorsArtis VenturesBlack FlagCivilization Ventures Management, LlcFoundersX VenturesGaingelsHarpoon Ventures+10 more
__Twitter.png)
Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.
AI & Machine LearningBiotechMedical DevicesNew York, US
Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Co-Founder)inMat Legut(Co-Founder and CEO)in
BoardVasudev Bailey(Director)in
Co-investorsArtis VenturesCivilization Ventures Management, LlcFusionGaingelsHAWKTAILAlexandria+2 more
PathPresenter is a digital pathology platform used for viewing, sharing, and managing pathology images in clinical, research, and educational settings.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Raj Singh(Founder)Rajendra Singh(Co-founder)inCory Batenchuk(Senior Vice President, Operations & Co-founder)inKV Acharya(System Architect & Co-founder)inPatrick Myles(Chief Executive Officer)in
Co-investorsAvant BioModi Ventures
Spline is a web-based collaborative design platform for creating and shipping production-ready interactive 2D and 3D experiences to web, iOS, and Android.
AI & Machine LearningCreator EconomyDeveloper ToolsEnterprise SoftwareFuture of WorkReston, US
Alejandro Leon(Founder)inAlejandro León(Founder)inGuillaume Gouessan(CTO)Caroline Mack(COO)Ale test(Tester)Gabor Pribek(Head of Design)
Co-investorsChapter OneFirestreak VenturesFirst Round CapitalGaingelsGradient VenturesLeonis Capital+19 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.